Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) (LUS-COVID19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04393402
Recruitment Status : Recruiting
First Posted : May 19, 2020
Last Update Posted : May 19, 2020
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice

Tracking Information
First Submitted Date May 15, 2020
First Posted Date May 19, 2020
Last Update Posted Date May 19, 2020
Actual Study Start Date March 20, 2020
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: May 18, 2020)
LUS applicability with COVID 19 [ Time Frame: 10 months ]
In dorsal position, or in prone position, the two hemithorax will be subdivided in 6 parts, and a score will be attributed with the following criteria : A-Lines (0 point), > 3 B-lines (1 point), B-Lines coalscent (2 points), and pulmonary consolidation (3 points). For the echography we can use a convexe sonde, or a "cardiac" sonde.
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures
 (submitted: May 18, 2020)
  • Radiographic correlation (chest Xray and tomodensitometry) [ Time Frame: 10 months ]
    Comparison between Xray / CT scan exam and LUS
  • LUS Mortality prediction [ Time Frame: 10 months ]
    according to LUS score, ventilatory mode and parameters, medical history and bood analysis results
  • Prediction of Prone position response [ Time Frame: 10 months ]
    comparison of LUS score depending of the position used for performing LUS
Original Secondary Outcome Measures Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19)
Official Title Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care
Brief Summary

It might be necessary with Sars-Cov2 pneumopathy patient to repeat thoracic images, the tomodensitometry ones in particular. This task is difficult and nearly impossible for several reasons: respiratory and hemodynamic unstable patient, prone position and due to the high contagious nature of the disease.

The lung ultrasound is an easy tool, fast (between 5 and 10 minutes) and as a limited training.

In the context of the Sars-Cov2 epidemic, Buonsenso and al case report depict the first lung ultrasound for a Covid 19 patient.

Peng and al in Intensive Care Medicine accentuate the usefulness of this particular technic.

In the American Journal of Respiratory and Critical Care Medicine, a study has been published as a point-of-care, in which the doctors reported using the lung ultrasound with intensive and critical care patient.

In Critical Care 2016, it has been showed that ultrasound allowed with neat precisions, to predict severe ARDS patient response to the prone position, all-cause.

Another researchers team found a good correlation between lung ultrasound, the SOFA, APACHE II, CPIS score, and patient mortality.

And a new applicability in the pulmonary recruitment by PEEP titration has been presented.

The aim of this study is to evaluate the lung ultrasound in Covid19 ARDS.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Patient with diagnose of Covid 19 by usully method, and admitted in critical care unit for oxygen-therapy or ventilatory support.
Condition COVID
Intervention Procedure: lung ultrasound (LUS)
Patients with Covid-19 Disease and admitted in critical care unit will be performed a LUS
Study Groups/Cohorts Patients with Covid-19 and admitted in critical care unit
Intervention: Procedure: lung ultrasound (LUS)
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: May 18, 2020)
14
Original Estimated Enrollment Same as current
Estimated Study Completion Date December 31, 2020
Estimated Primary Completion Date December 31, 2020   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Diagnosed Sars-Cov2 patient, with PCR method qualitative or quantitative as usual.
  • Intensive or critical care admission
  • ARDS with PaO2/FiO2 <300 at the admission
  • Ventilatory support or oxygen-therapy

Exclusion Criteria:

  • Age < 18 years-old
  • Pregnancy
  • Patient with tutor- or curatorship or in prison
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 95 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts
Contact: Jean DELLAMONICA, MD, PhD +334 92 03 55 10 dellamonica.j@chu-nice.fr
Contact: Romain LOMBARDI +336 69 03 26 16 lombardi.r@chu-nice.fr
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT04393402
Other Study ID Numbers 20reamedcovid03
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Plan Description: No data sharing plan has been established
Responsible Party Centre Hospitalier Universitaire de Nice
Study Sponsor Centre Hospitalier Universitaire de Nice
Collaborators Not Provided
Investigators Not Provided
PRS Account Centre Hospitalier Universitaire de Nice
Verification Date May 2020